Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Uveitis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global uveitis treatment market reached a value of US$ 550 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 5.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Uveitis treatment refers to various therapeutic procedures for treating inflammation in the uvea and surrounding tissues. The disease is characterized by blurred vision, dark or floating spots in the vision, redness of eye and sensitivity to light. Some of the commonly used uveitis treatment methods include topical, systemic and local corticosteroids, immunosuppressants, monoclonal antibodies, cycloplegic agents, antibiotics, analgesics and antivirals and antifungal medicines. These therapeutics are directed toward reducing inflammation, alleviating pain, preventing further tissue damage and restoring vision loss and can be used to treat conditions, including anterior uveitis, intermediate uveitis, posterior uveitis and panuveitis.

The increasing prevalence of optical infections and chronic eye disorders across the globe represents one of the key factors driving the growth of the market. Uveitis is highly prevalent among individuals suffering from diabetes, eye injuries, cataract, glaucoma, cystoid macular edema, band keratopathy and autoimmune and inflammatory disorders. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. In line with this, the increasing awareness regarding the available treatment alternatives for managing uveitis has resulted in a significant increase in the demand for corticosteroid treatments among patients and healthcare providers. Additionally, various technological advancements in the treatment alternatives, such as the development of non-steroidal injectables and anti-tumor necrosis factor (TNF) drugs, are acting as other growth-inducing factors. These biological therapeutic agents are effective in the treatment of chronic uveitis and are administered as subcutaneous injections. Other factors, including the implementation of favorable initiatives by the governments to promote public health, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global uveitis treatment market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, Treatment Type, Disease Type, Cause and Distribution Channel.

Breakup by Treatment Type:

  • Corticosteroids
  • Immunosuppressant
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antivirals
  • Antifungal
  • Analgesics
     

Breakup by Disease Type:

  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis
     

Breakup by Cause:

  • Infectious
  • Non-infectious
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AbbVie Inc., Alimera Sciences Inc., Bausch & Lomb Incorporated (Bausch Health), Enzo Biochem Inc., Eyegate Pharmaceuticals Inc., Eyepoint Pharmaceuticals Inc., Novartis AG, Regeneron Pharmaceuticals Inc. and Santen Pharmaceutical Co. Ltd.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Treatment Type, Disease Type, Cause, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AbbVie Inc., Alimera Sciences Inc., Bausch & Lomb Incorporated (Bausch Health), Enzo Biochem Inc., Eyegate Pharmaceuticals Inc., Eyepoint Pharmaceuticals Inc., Novartis AG, Regeneron Pharmaceuticals Inc. and Santen Pharmaceutical Co. Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global uveitis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global uveitis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the disease type?
  • What is the breakup of the market based on the cause?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global uveitis treatment market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Uveitis Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Treatment Type
    6.1    Corticosteroids
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Immunosuppressant
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Monoclonal Antibodies
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Cycloplegic Agents
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Antibiotics
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Antivirals
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Antifungal
        6.7.1 Market Trends
        6.7.2 Market Forecast
    6.8    Analgesics
        6.8.1 Market Trends
        6.8.2 Market Forecast
7    Market Breakup by Disease Type
    7.1    Anterior Uveitis
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Posterior Uveitis
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Intermediate Uveitis
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Panuveitis
        7.4.1 Market Trends
        7.4.2 Market Forecast
8    Market Breakup by Cause
    8.1    Infectious
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Non-infectious
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Retail Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Online Pharmacies
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Others
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AbbVie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Alimera Sciences Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio 
           15.3.2.3 Financials
        15.3.3    Bausch & Lomb Incorporated (Bausch Health)
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 SWOT Analysis
        15.3.4    Enzo Biochem Inc.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Eyegate Pharmaceuticals Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
           15.3.5.3 Financials
        15.3.6    Eyepoint pharmaceuticals Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
           15.3.6.3 Financials
        15.3.7    Novartis AG
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Regeneron Pharmaceuticals Inc
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio 
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Santen Pharmaceutical Co. Ltd.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis

List of Figures

Figure 1: Global: Uveitis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Uveitis Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Uveitis Treatment Market: Breakup by Treatment Type (in %), 2020
Figure 4: Global: Uveitis Treatment Market: Breakup by Disease Type (in %), 2020
Figure 5: Global: Uveitis Treatment Market: Breakup by Cause (in %), 2020
Figure 6: Global: Uveitis Treatment Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Uveitis Treatment Market: Breakup by Region (in %), 2020
Figure 8: Global: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Uveitis Treatment (Corticosteroids) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Uveitis Treatment (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Uveitis Treatment (Immunosuppressant) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Uveitis Treatment (Immunosuppressant) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Uveitis Treatment (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Uveitis Treatment (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Uveitis Treatment (Cycloplegic Agents) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Uveitis Treatment (Cycloplegic Agents) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Uveitis Treatment (Antibiotics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Uveitis Treatment (Antibiotics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Uveitis Treatment (Antivirals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Uveitis Treatment (Antivirals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Uveitis Treatment (Antifungal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Uveitis Treatment (Antifungal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Uveitis Treatment (Analgesics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Uveitis Treatment (Analgesics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Uveitis Treatment (Anterior Uveitis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Uveitis Treatment (Anterior Uveitis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Uveitis Treatment (Posterior Uveitis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Uveitis Treatment (Posterior Uveitis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Uveitis Treatment (Intermediate Uveitis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Uveitis Treatment (Intermediate Uveitis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Uveitis Treatment (Panuveitis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Uveitis Treatment (Panuveitis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Uveitis Treatment (Infectious) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Uveitis Treatment (Infectious) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Uveitis Treatment (Non-infectious) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Uveitis Treatment (Non-infectious) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Uveitis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Uveitis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Uveitis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Uveitis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Global: Uveitis Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Global: Uveitis Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Global: Uveitis Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Global: Uveitis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: North America: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: North America: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: United States: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: United States: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Canada: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Canada: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Asia Pacific: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Asia Pacific: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: China: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: China: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Japan: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Japan: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: India: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: India: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: South Korea: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: South Korea: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Australia: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Australia: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Indonesia: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Indonesia: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Others: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Others: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Europe: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Europe: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Germany: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Germany: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: France: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: France: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: United Kingdom: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: United Kingdom: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Italy: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Italy: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Spain: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: Spain: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Russia: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Russia: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Others: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Others: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Latin America: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Latin America: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Brazil: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Brazil: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Mexico: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: Mexico: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 89: Others: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 90: Others: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 91: Middle East and Africa: Uveitis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 92: Middle East and Africa: Uveitis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 93: Global: Uveitis Treatment Industry: SWOT Analysis
Figure 94: Global: Uveitis Treatment Industry: Value Chain Analysis
Figure 95: Global: Uveitis Treatment Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Uveitis Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Uveitis Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 3: Global: Uveitis Treatment Market Forecast: Breakup by Disease Type (in Million US$), 2021-2026
Table 4: Global: Uveitis Treatment Market Forecast: Breakup by Cause (in Million US$), 2021-2026
Table 5: Global: Uveitis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Global: Uveitis Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Uveitis Treatment Market Structure
Table 8: Global: Uveitis Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links